This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Interview with Glaucoma Researcher Tonia Rex, PhD

GRF awarded Dr. Tonia Rex the Shaffer Prize for Innovative Glaucoma Research in 2012 for her project investigating a neuroprotective therapy in a model of inherited glaucoma.

Problems with Prescription Eye Drop Refills?

Some glaucoma patients who use eye drop medications have been faced with more stringent restrictions on their prescriptions.

Biomarkers for Glaucoma

What is a biomarker? A biomarker is an indicator of a biological condition that, in some cases, can assist in the diagnosis and management of disease.

How Compliance Can Help Save Your Sight

Seven tips to help make it easier to stay compliant with your medication regimen.

Understanding Who is at High Risk of Having Glaucoma

Nearly half of those with glaucoma do not know they have the disease. This has been shown repeatedly in studies conducted in developed countries.

Glaucoma and Driving

Answers to common questions about driving safely if you have glaucoma.

Do It Right To Preserve Your Sight

The only proven treatment to prevent glaucoma from developing or getting worse is to lower the pressure in the eye.

Who knew I had Glaucoma? I didn’t.

Neither do 1.5 million other Americans. Approximately half of the glaucoma population in the U.S. goes undiagnosed.

What Causes Vision Loss in Glaucoma?

Researchers hope that by studying other neurodegenerative diseases, we can identify common causes that will help us develop new treatments for glaucoma.

Aerobic Exercise for Neuroprotection

Many glaucoma patients ask their doctors, “What else can I do to help preserve my vision?” One answer may be to get off the couch—and get moving.

Canaloplasty: A Surgical Alternative for Glaucoma

Canaloplasty is one of several surgical alternatives to lower pressure for patients with glaucoma.

Roger McGuinn: Singer-Songwriter and Guitarist

In the midst of a busy schedule that goes with a successful music career, Roger McGuinn has always made time for regular eye exams.

What is Bleb Needling?

Bleb needling is generally considered a safe outpatient procedure performed in the doctor’s office.

Glaucoma Implant Surgery

A glaucoma drainage implant is a small device placed in the eye to treat glaucoma.

Update on Alternative Glaucoma Medications

In research studies, vitamins have had little or no effect as a glaucoma treatment.

If I Have a Large Optic Nerve Cup, Does That Mean I Have Glaucoma?

The second most significant risk factor for the development of chronic open-angle glaucoma is the size of the central cup “cupping” of the optic nerve head.

Hypotony

I’ve recently had filtering surgery, and now my eye pressure is very low. My doctor says I have a condition called hypotony. Can you tell me what this is?

Eye Drops May Delay or Prevent Glaucoma in African Americans

Eye drops that reduce elevated pressure inside the eye can delay or possibly prevent the onset of glaucoma in African Americans at higher risk for developing the disease, researchers have found.

Catalyst for a Cure Roundtable (CFC1)

These videos with the Catalyst for a Cure researchers were filmed during a roundtable interview discussion in January 2011 at the Palace Hotel in San Francisco.

Catalyst for a Cure (CFC1) Report: Nine Years of Innovation

The Catalyst For a Cure has reshaped the direction of glaucoma research by taking a pioneering approach that should become a model for research in other diseases.

Stephanie Handler: Discovering Glaucoma

Stephanie was shocked to learn she had glaucoma after discovering that the vision in her left eye was blurred.

Ron Payne: “I’ve Seen What Glaucoma Can Do”

Ron Payne of Philadelphia has seen both his mother and his sister lose their sight to glaucoma.

Catalyst for a Cure 2011 Progress Report

The research team identified a period of vulnerability for retinal ganglion cells early in the disease, when these cells are more sensitive to metabolic insults and stressors.

Surgical Treatments for Pediatric Glaucoma

While there are both medical and surgical treatments for pediatric glaucoma, surgery remains the mainstay of therapy for primary infantile glaucoma as well as many other forms of glaucoma in children.

Catalyst for a Cure Identifies Key Early Events in Glaucoma

During the year 2009, the investigators of the Catalyst for a Cure (CFC1) consortium worked together to probe how retinal ganglion cells are damaged and decline in glaucoma.